Maxwell Dickson Launches Crowdfunding for Breast Cancer with Invites to a Red Carpet Event

Maxwell Dickson Launches Crowdfunding for Breast Cancer with Invites to a Red Carpet Event
0
(0)

An unusual pairing in Los Angeles has just been announced in support of the most common, but deadly cancer among women — breast cancer. Maxwell Dickson, an art company that specializes in modern and contemporary wall art and canvas prints, is working with the Breast Cancer Care & Research Fund (BCCRF) to raise $200,000 to fund research efforts on breast cancer. James Freeman, the CEO of Maxwell Dickson, said that they are very excited to engage the community for a cause.

The crowdfunding initiative was launched on September 9th and will conclude next month, October 11th. It will be on Crowdrise.com, a website founded by actor Edward Norton that facilitates online fundraising projects for nonprofit organizations.

When the crowdfunding is completed on October 11th, Maxwell Dickson will be hosting an exhibit entitled, “Pink Tie Affair” at the California Market Center during the LA Fashion Week. The organizers are expecting hundreds of attendees, including A-list personalities. All proceeds of the event will go to the BCCRF.

There is still much to be discovered and improved on in breast cancer research. To support the campaign, contributors can log on to Crowdrise.com and make a small donation worth at least $25. Every donation earns an exclusive invitation to the Pink Tie Affair, where attendees can enjoy gourmet food, wine, art, musical performances, art exhibits, and even massages. People are calling it the most unique red carpet event of the year, as it puts the spotlight on breast cancer awareness and support.

[adrotate group=”3″]

Another highlight of the Pink Tie Affair will be the debut of a new art collection from Maxwell Dickson. These limited edition works are “staff inspired” and will be auctioned off during the event. After the pieces are purchased, the company will be releasing only 250 prints.

To know more about this event, contact Chelsea Rush at 877-484-6566, or via e-mail.

 

Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
×
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
Latest Posts
  • Phesgo approved
  • FDA, Leronlimab
  • Tukysa, EU approval
  • LUM Imaging System, fast track

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?